Trial intelligence / Profile preview

Topical cetirizine for hair growth in women with female pattern hair loss

IRCT20200521047536N1Phase 3Completed

Sponsor
Mashhad University of Medical Sciences
Start
Apr 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of cetirizine in androgenetic alopecia (AGA), sponsored by Mashhad University of Medical Sciences. Started Apr 2019; status: completed.

02

Drugs

cetirizine
03

Conditions

androgenetic alopecia (AGA)

Beyond the preview

Go deeper on IRCT20200521047536N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20200521047536N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call